500-Bedded Odisha COVID-19 Hospital Becomes Operational in KIMS

Bhubaneswar: A 500-Bedded Odisha COVID-19 Hospital managed and run by Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar has become operational from 2nd April 2020.

Govt. of Odisha is financing equipment and operational costs through CSR policy of OMC. Naveen Patnaik, Hon’ble Chief Minister of Odisha declared the hospital operational in the presence of Dr. Achyuta Samanta, Founder, KIIT & KISS; Dr. Subrat Acharya, Pro-Chancellor, KIIT Deemed to University and Dr. Bishnu Prasad Panigrahi, CEO, KIMS today.

The Odisha COVID Hospital has 500-bed infrastructure, including 50 critical care beds. It is well-equipped with latest instruments and other facilities. The Odisha COVID Hospital is functioning from a dedicated block of KIMS having a dedicated and exclusive team of doctors, nurses, paramedics and housekeeping staff. COVID suspects as well COVID patients will have a separate entrance and exit to KIMS campus and not intermingle with non COVID patients. The Hospital has no linkage with other departments of KIMS and is led by Dr. Bishnu Prasad Panigrahi under the guidance of Dr. Subrat Acharya.

“The Hospital adheres to the standard best practices and follows WHO and ICMR guidelines. It will be functional round the clock”, informed Dr. A. Samanta.

Related Posts

Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge

Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…

WHO Advises Against Antibiotics for COVID-19 Without Bacterial Infection

Geneva, August 7, 2025 — The World Health Organization (WHO) has issued strong updated clinical recommendations: do not prescribe antibiotics to COVID-19 patients — whether severe or mild — unless…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Senores Pharma to Buy Two Teva ANDAs

Senores Pharma to Buy Two Teva ANDAs

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lilly launches Mounjaro KwikPen in India

Lilly launches Mounjaro KwikPen in India